What is chemo brain, and what can be done for it?
Many cancer patients go to the Internet with their questions about side effect management. But the information they glean is from reliable sources—other cancer patients.
The key to managing this late effect is patient education because it can manifest long after patients complete radiotherapy.
A common side effect of cancer treatment, including radiotherapy, is diarrhea. Treatment is based on its cause and severity.
Patients undergoing chemotherapy for hematologic cancers are at risk for this complication. The review can help you learn how to assess their risk.
What can we do for patients who develop rashes associated with cancer chemotherapies?
What can be done to decrease the severity of peripheral neuropathy experienced by patients receiving chemotherapy?
Methylprednisolone (Solu-Medrol) and hydrocortisone (Solu-Cortef) are used to treat infusion reactions to chemotherapy and other anticancer treatments. Some clinicians seem to favor one over the other. Is there a significant difference between the two or is it just a matter of clinician preference?
Diligent patient education that addresses adherence and persistence issues can optimize outcomes in patients with gastrointestinal stromal tumors.
The Advisor Forum addresses a question about medications that can treat hot flushes in women receiving tamoxifen.
Topical 1% sildenafil cream is well-tolerated, feasible to administer, and may help mitigate hand-foot syndrome, found research presented at the 38th ONS Annual Congress.
"4MAT" education can help individualize and optimize patient use of an evidence-based skin care protocol based on the ONS Putting Evidence into Practice guidelines for radiation dermatitis, found research presented at the ONS 38th Annual Congress.
NeutraSal®, a new supersaturated calcium phosphate oral rinse, significantly mitigated the severity of acute mucosal toxicity, a study presented at the ONS 38th Annual Congress has found.
Mice that produced the Smad7 protein in the oral cavity were dramatically more resistant to radiation-induced oral mucositis than were controls.
Among patients with painful chemotherapy-induced peripheral neuropathy, use of the antidepressant drug duloxetine for 5 weeks resulted in a greater reduction in pain compared with placebo, according to a new study.
A study has found that duloxetine effectively decreases pain for patients with chemotherapy-related peripheral neuropathy, especially for those who received the drug as initial treatment.
Sudden exhaustion syndrome is being proposed as a new descriptor to better characterize abrupt fatigue in persons with cancer.
Oral melatonin does not improve appetite, weight, or quality of life for patients with cachexia due to advanced cancer.
Online discussion of side effects associated with aromatase inhibitors is common and often related to drug-switching and discontinuation.
A set of proteins circulating in blood may flag the presence of lymphedema, which is difficult to diagnose before the onset of physical symptoms.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|